Donoghue Forlines LLC Makes New Investment in HCA Healthcare, Inc. $HCA

Donoghue Forlines LLC bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, HoldingsChannel reports. The institutional investor bought 7,352 shares of the company’s stock, valued at approximately $2,817,000.

Other large investors have also recently made changes to their positions in the company. Cheviot Value Management LLC bought a new position in HCA Healthcare during the first quarter valued at about $26,000. Saudi Central Bank purchased a new stake in shares of HCA Healthcare during the 1st quarter worth approximately $26,000. WPG Advisers LLC bought a new position in HCA Healthcare during the first quarter valued at $27,000. Ameriflex Group Inc. purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at $27,000. Finally, Chung Wu Investment Group LLC purchased a new stake in HCA Healthcare during the second quarter valued at about $27,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently commented on HCA shares. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $417.00 price objective on shares of HCA Healthcare in a report on Monday, October 27th. Royal Bank Of Canada lifted their price target on HCA Healthcare from $449.00 to $482.00 and gave the company an “outperform” rating in a research report on Monday, October 27th. KeyCorp upped their price target on HCA Healthcare from $465.00 to $475.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. Wolfe Research cut shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Finally, Mizuho raised their price target on shares of HCA Healthcare from $475.00 to $505.00 and gave the company an “outperform” rating in a report on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $474.53.

Insider Activity

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

NYSE HCA opened at $473.42 on Friday. The company has a market capitalization of $108.03 billion, a P/E ratio of 18.30, a P/E/G ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $479.43. The company has a fifty day moving average of $432.52 and a 200-day moving average of $395.09.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the business earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.